AR104265A1 - Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel - Google Patents
Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de pielInfo
- Publication number
- AR104265A1 AR104265A1 ARP160101022A ARP160101022A AR104265A1 AR 104265 A1 AR104265 A1 AR 104265A1 AR P160101022 A ARP160101022 A AR P160101022A AR P160101022 A ARP160101022 A AR P160101022A AR 104265 A1 AR104265 A1 AR 104265A1
- Authority
- AR
- Argentina
- Prior art keywords
- prevention
- treatment
- combination
- protease inhibitor
- active principle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/56—Protease inhibitors from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Combinación que comprende al menos un inhibidor de proteasa, que puede ser diferentes orígenes, tal como plantas, frutas, salvado de arroz, semillas de frijol, soja o papa y al menos un principio activo adicional, seleccionado de óxido de zinc, dexpantenol, pantenol, cloruro de benzalconio, cetrimida, clotrimazol, nistatina, dimeticona, aloe vera, o caléndula y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por orina y/o heces y como adyuvante en la reparación de piel. Combinación en asociación con principios activos adicionales y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por proteasas en las heces y como adyuvante en la reparación de piel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2015/058451 WO2016165783A1 (en) | 2015-04-17 | 2015-04-17 | Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR104265A1 true AR104265A1 (es) | 2017-07-05 |
Family
ID=52988064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160101022A AR104265A1 (es) | 2015-04-17 | 2016-04-14 | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP3283093B1 (es) |
KR (1) | KR102359285B1 (es) |
CN (1) | CN107683144B (es) |
AR (1) | AR104265A1 (es) |
BR (1) | BR112017022286A2 (es) |
CO (1) | CO2017010543A2 (es) |
DK (1) | DK3283093T3 (es) |
ES (1) | ES2830379T3 (es) |
HK (1) | HK1246205A1 (es) |
HR (1) | HRP20201777T1 (es) |
HU (1) | HUE052035T2 (es) |
MX (1) | MX2017013352A (es) |
MY (1) | MY196133A (es) |
PH (1) | PH12017501889A1 (es) |
PT (1) | PT3283093T (es) |
RS (1) | RS61576B1 (es) |
SG (1) | SG11201708214UA (es) |
WO (1) | WO2016165783A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112402273B (zh) * | 2020-12-01 | 2023-10-03 | 金发拉比妇婴童用品股份有限公司 | 一种改善婴幼儿红屁股的膏霜及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9908565A (pt) * | 1998-03-12 | 2000-12-12 | Procter & Gamble | Artigo absorvente e processo para reduzir a atividade enzimática de uma enzima fecal em uma parte da pele de um usuário de um artigo absorvente |
EP0958833A1 (en) * | 1998-05-20 | 1999-11-24 | Erasmus Universiteit Rotterdam | Methods and means for preventing or treating inflammation |
US6207596B1 (en) * | 1998-11-09 | 2001-03-27 | The Procter & Gamble Company | Disposable premoistened wipe containing an antimicrobial protease inhibitor |
US7005557B2 (en) * | 2001-07-03 | 2006-02-28 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
US20050175719A1 (en) * | 2004-02-05 | 2005-08-11 | Ying Sun | Procyanidins for treatment and prevention of enzymatic irritation to the skin |
EP1586336A1 (en) * | 2004-04-06 | 2005-10-19 | JOHNSON & JOHNSON GmbH | Compositions containing copper salts and soy products |
NZ547991A (en) * | 2005-06-22 | 2008-08-29 | Bristol Myers Squibb Co | Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes |
-
2015
- 2015-04-17 BR BR112017022286A patent/BR112017022286A2/pt active Search and Examination
- 2015-04-17 RS RS20201331A patent/RS61576B1/sr unknown
- 2015-04-17 EP EP15717170.3A patent/EP3283093B1/en active Active
- 2015-04-17 WO PCT/EP2015/058451 patent/WO2016165783A1/en active Application Filing
- 2015-04-17 MY MYPI2017703833A patent/MY196133A/en unknown
- 2015-04-17 HU HUE15717170A patent/HUE052035T2/hu unknown
- 2015-04-17 SG SG11201708214UA patent/SG11201708214UA/en unknown
- 2015-04-17 ES ES15717170T patent/ES2830379T3/es active Active
- 2015-04-17 DK DK15717170.3T patent/DK3283093T3/da active
- 2015-04-17 MX MX2017013352A patent/MX2017013352A/es unknown
- 2015-04-17 PT PT157171703T patent/PT3283093T/pt unknown
- 2015-04-17 CN CN201580078893.4A patent/CN107683144B/zh active Active
- 2015-04-17 KR KR1020177031864A patent/KR102359285B1/ko active IP Right Grant
-
2016
- 2016-04-14 AR ARP160101022A patent/AR104265A1/es unknown
-
2017
- 2017-10-13 CO CONC2017/0010543A patent/CO2017010543A2/es unknown
- 2017-10-18 PH PH12017501889A patent/PH12017501889A1/en unknown
-
2018
- 2018-05-08 HK HK18105937.5A patent/HK1246205A1/zh unknown
-
2020
- 2020-11-04 HR HRP20201777TT patent/HRP20201777T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180003553A (ko) | 2018-01-09 |
SG11201708214UA (en) | 2017-11-29 |
PH12017501889A1 (en) | 2018-03-05 |
HRP20201777T1 (hr) | 2021-01-08 |
ES2830379T3 (es) | 2021-06-03 |
DK3283093T3 (da) | 2020-11-09 |
WO2016165783A1 (en) | 2016-10-20 |
CN107683144A (zh) | 2018-02-09 |
BR112017022286A2 (pt) | 2018-07-10 |
RS61576B1 (sr) | 2021-04-29 |
CO2017010543A2 (es) | 2018-03-09 |
MY196133A (en) | 2023-03-16 |
PT3283093T (pt) | 2020-11-03 |
KR102359285B1 (ko) | 2022-02-07 |
MX2017013352A (es) | 2018-06-22 |
HUE052035T2 (hu) | 2021-04-28 |
EP3283093A1 (en) | 2018-02-21 |
CN107683144B (zh) | 2020-08-07 |
EP3283093B1 (en) | 2020-09-16 |
HK1246205A1 (zh) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
WO2015193740A3 (en) | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor | |
BR112013028666A2 (pt) | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo | |
CL2017002825A1 (es) | Formulaciones de tpp1 y métodos para tratar la enfermedad de cln2 | |
CR9816A (es) | Composicion sinergetica y metodo de uso | |
WO2015026494A3 (en) | Methods for treating tissue fibrosis | |
CO2017011778A2 (es) | Un inhibidor de la actividad del csf-1r y composiciones farmaceuticas que lo comprenden | |
WO2016004413A3 (en) | Gls1 inhibitors for treating disease | |
BR112019006880A2 (pt) | compostos e composições para tratamento de leishmaniose e métodos de diagnóstico e tratamen-to usando os mesmos | |
BR112014000795A2 (pt) | uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias | |
CO2017010543A2 (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
CL2017002630A1 (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
DOP2017000238A (es) | Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel | |
AR064214A1 (es) | Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas | |
DK3727414T3 (da) | Salvia haenkei-ekstrakt som aktivt middel i vævsreepiteliserings- og ardannelsesprocesser | |
WO2015044317A3 (en) | Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis | |
GB202019606D0 (en) | Hair treatment products based on biodegradable active ingredients | |
PE20180161A1 (es) | Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de piel | |
TH1701006167A (th) | สารรวมของอย่างน้อยที่สุดหนึ่งตัวยับยั้งโปรตีเอส และอย่างน้อยที่สุดหนึ่งสารออกฤทธิ์สำหรับการใช้ในการป้องกัน และ/หรือ การรักษารอยโรคที่ผิวหนัง | |
EP4293036A3 (en) | Structure of gii.4 norovirus protease -design of broad-spectrum protease inhibitors | |
BR112017020100A2 (pt) | composições herbicidas compreendendo isoxaflutol e diflufenican | |
大島康子 | Characteristics of IgA nephropathy in advanced‑age patients | |
Khalkhali et al. | The impact of sensitivity training program on the general health of divorced women | |
CL2019003277A1 (es) | Composición cosmética de textura oleosa, uso y método para prevención y/o tratamiento de las señales de envejecimiento externo y del estrés cutáneo. | |
RU2009104276A (ru) | Антиульцерогенное средство |